Pharmaceutical marketing has real and proven value - Characteristics of materials distributed by drug companies: Four points of view

被引:12
作者
Beary, JF
机构
关键词
D O I
10.1007/BF02599032
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
引用
收藏
页码:635 / 636
页数:2
相关论文
共 5 条
[1]   EFFECT OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS ON VENTRICULAR REMODELING AND SURVIVAL FOLLOWING MYOCARDIAL-INFARCTION [J].
BECKWITH, C ;
MUNGER, MA .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (06) :755-766
[2]  
Peltzman S., 1975, Drug Development and Marketing
[3]   Characteristics of materials distributed by drug companies - An evaluation of appropriateness [J].
Stryer, D ;
Bero, LA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 1996, 11 (10) :575-583
[4]  
SURESH CG, 1993, LANCET, V341, P1540
[5]   THE CLINICAL-VALUE OF FDA CLASS-C DRUGS APPROVED FROM 1981 TO 1988 [J].
YASUDA, SU ;
WOOSLEY, RL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (06) :577-582